广州多浦乐电子科技股份有限公司 第二届董事会提名、薪酬与考核委员会 关于独立董事候选人任职资格的审查意见 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运 作》（以下简称"《规范运作》"）、《上市公司独立董事管理办法》 （以下简称"《管理办法》"）等法律法规、规范性文件和《广州多浦 乐电子科技股份有限公司章程》（以下简称"《公司章程》"）的有关 规定，我们作为广州多浦乐电子科技股份有限公司（以下简称"公司"） 的第二届董事会提名、薪酬与考核委员会委员，对公司第三届董事会独 立董事候选人的任职资格进行了审查，发表意见如下： 公司第三届董事会独立董事候选人徐悦、杨浩楠、张建海具备《规 范运作》《管理办法》等规定的担任上市公司独立董事的任职条件、专 业背景和工作经验，符合相关法律法规规定的任职资格和独立性等要求。 其中，徐悦为会计专业人士。候选人徐悦、杨浩楠、张建海目前尚未取 得独立董事资格证书，其承诺将尽快参加最近一次的独立董事资格培训 并取得深交所认可的独立董事资格证书。 上述独立董事候选人均不存在《公司法》《规范运作》《管理办法》 ...

证券代码：301528 证券简称：多浦乐 公告编号：2025-069 广州多浦乐电子科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 广州多浦乐电子科技股份有限公司 2025 年第三季度报告 3.第三季度财务会计报告是否经过审计 □是 否 1 广州多浦乐电子科技股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 增减 | | 比上年同期增减 | | 营业收入（元） | 49,246,343.95 | ...

证券代码：301528 证券简称：多浦乐 公告编号：2025-065 广州多浦乐电子科技股份有限公司 第二届监事会第二十三次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 证券代码：301528 证券简称：多浦乐 公告编号：2025-065 的《关于取消监事会并修订<公司章程>的公告》。 广州多浦乐电子科技股份有限公司（以下简称"公司"）第二届监 事会第二十三次会议通知于 2025 年 10 月 24 日以通讯方式送达各位监事。 会议于 2025 年 10 月 28 日在公司会议室以现场及通讯表决相结合的方式 召开。会议应出席的监事 3 人，实际出席的监事 3 人，本次会议由监事 会主席纪轩荣先生召集并主持。 本次会议的召集、召开符合《中华人民共和国公司法》（以下简称"公 司法"）等相关法律、法规以及《广州多浦乐电子科技股份有限公司章程》 （以下简称"《公司章程》"）的规定，会议合法、有效。 二、监事会会议审议情况 1、审议通过了《关于取消监事会并修订<公司章程>的议案》 为进一步规范公司运作，完善公司治理，根据《中华人民 ...

证券代码：301528 证券简称：多浦乐 公告编号：2025-064 广州多浦乐电子科技股份有限公司 第二届董事会第二十三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 广州多浦乐电子科技股份有限公司（以下简称"公司"）第二届董 事会第二十三次会议通知于 2025 年 10 月 24 日以通讯方式送达全体董事。 会议于 2025 年 10 月 28 日在公司会议室以现场及通讯表决相结合的方式 召开。会议应出席的董事 7 人，实际出席的董事 7 人，本次会议由董事 长蔡庆生先生召集并主持，公司监事、高级管理人员列席了本次会议。 本次会议的召集、召开符合《中华人民共和国公司法》（以下简称"《公 司法》"）等相关法律、法规以及《广州多浦乐电子科技股份有限公司章 程》（以下简称"《公司章程》"）的规定，会议合法、有效。 二、董事会会议审议情况 1、审议通过了《关于取消监事会并修订<公司章程>的议案》 为进一步规范公司运作，完善公司治理，根据《中华人民共和国公 司法》《上市公司章程指引》等有关法律法规及规范性文件的规定，结合 公司 ...

Core Viewpoint - The company, Duople, is a leading provider of ultrasonic phased array testing equipment in China, focusing on non-destructive testing solutions across various industries, including special equipment, energy, aerospace, and third-party testing institutions [2]. Group 1: Company Overview - Duople has evolved from a manufacturer of ultrasonic probes to a specialized provider of industrial non-destructive testing equipment and solutions [2]. - The company has established a strong customer base in sectors such as special equipment, rail transportation, energy, metallurgy, aerospace, nuclear power, third-party testing institutions, and research institutions [2]. Group 2: Product Applications - The company's products for metal detection are designed to identify potential defects in metals, such as voids, slag inclusions, delaminations, and cracks, and are widely applicable to metal substrates like castings and forgings [2]. - In the oil and petrochemical sector, Duople has developed adjustable curvature phased array probes and automatic detection devices for pipeline corrosion, fulfilling various detection needs including oil pipeline corrosion and in-service inspections [2]. Group 3: Market Activity - As of October 22, 2025, Duople's stock closed at 59.9 yuan, down 2.2%, with a turnover rate of 1.9% and a trading volume of 6,047 hands, amounting to a transaction value of 36.4572 million yuan [1]. - On the same day, the net outflow of main funds was 387.25 thousand yuan, while retail investors saw a net inflow of 703.65 thousand yuan [4].

Group 1 - The company has a diverse customer base in various sectors, including special equipment, rail transportation, aerospace, energy and power, steel metallurgy, new energy vehicles, third-party testing organizations, and higher education institutions [1] - The company's products are specifically designed to provide targeted services for oil and metal probe companies [1] - The company appreciates investor interest and engagement regarding its product applications [1]

Core Viewpoint - Duople is a leading enterprise in the domestic ultrasonic phased array testing equipment sector, demonstrating strong profitability and growth potential in the non-destructive testing industry [1] Company Performance - In H1 2025, the company achieved revenue of 80 million yuan, representing a year-on-year growth of 56.2% [1] - The net profit attributable to the parent company reached 20 million yuan, with a year-on-year increase of 12.15% [1] - The company's gross profit margin has maintained above 70% from 2020 to 2024, positioning it at the upstream of the industry [1] Industry Outlook - The non-destructive testing industry is rapidly developing, with significant potential for domestic substitution of imports [1] - The establishment of industry standards is driving demand for the replacement of testing methods, opening up growth opportunities for phased array testing [1] - The company's strong technical barriers and the expansion of medical and automation demands are expected to create a second growth point for the company [1] Investment Rating - The company is rated as a "buy" based on its strong technology and profitability, along with the broad market space in non-destructive testing, indicating expectations for sustained stable growth in performance [1]

Core Insights - The company is a leading domestic provider of ultrasonic phased array testing equipment, demonstrating strong profitability and growth potential in the non-destructive testing (NDT) industry [1][3] Group 1: Company Performance - In H1 2025, the company achieved revenue of 80 million yuan, a year-on-year increase of 56.2%, and a net profit attributable to shareholders of 20 million yuan, up 12.15% year-on-year [1] - The company's gross margin has consistently remained above 70% from 2020 to 2024, positioning it at the upstream of the industry [1] Group 2: Industry Growth Potential - The ultrasonic testing market is projected to grow from 2.92 billion USD in 2024 to 4.60 billion USD by 2029, with a compound annual growth rate (CAGR) of 9.5% [1] - The global NDT market is expected to expand from approximately 11.6 billion USD in 2024 to 18.4 billion USD by 2029, with ultrasonic testing expected to capture the largest market share [1] Group 3: Technological Advancements - The establishment of industry standards, such as "Non-destructive Testing of Pressure Equipment Part 15: Phased Array Ultrasonic Testing," is expected to drive the adoption of phased array testing in specialized equipment sectors [2] - Phased array technology offers advantages over traditional ultrasonic testing, including broader application range, lower missed detection rates, and clearer defect visualization, making it likely to gradually replace traditional methods [2] Group 4: Future Growth Drivers - The company has a strong R&D capability, holding 66 patents and participating in the formulation of multiple national and industry standards, which supports its competitive edge against international products [3] - The establishment of a wholly-owned subsidiary, Duople Medical, aims to enhance product development and customer outreach in the medical sector, while increasing demand for automation equipment is expected to boost overall profitability [3] Group 5: Investment Outlook - The company is rated as a "buy" due to its strong technology and profitability, with expectations for continued stable growth in performance [3] - Projected net profits for 2025, 2026, and 2027 are estimated at 90 million, 130 million, and 170 million yuan, respectively, with corresponding earnings per share (EPS) of 1.50, 2.10, and 2.74 yuan [3]

Group 1: Macro Insights - In September, exports increased significantly, reaching a six-month high, indicating the resilience of China's export sector. The export growth rate for Q3 was 6.5%, slightly higher than in Q1 and Q2, supporting the GDP growth target of "above 5%" for the year [2] - Imports surged by 7.4% year-on-year in September, marking the highest increase in a year and a half, with industrial metals like copper and iron ore, as well as integrated circuits, being the main drivers [2] - Looking ahead to Q4, export growth may slow due to high base effects and recent escalations in US-China tariffs, but it is expected to remain positive overall, with strong support from regions outside the US [2] Group 2: Company-Specific Insights - Duople (301528.SZ) is a leading domestic provider of ultrasonic phased array testing equipment, showing strong profitability with H1 2025 revenue of 80 million yuan, up 56.2% year-on-year, and a net profit of 20 million yuan, up 12.15% [6][7] - Kaishan (300257.SZ) is a leader in high-end equipment manufacturing and renewable energy, with a revenue of 4.235 billion yuan in 2024, a 1.64% increase, and a net profit of 320 million yuan, down 26.05% [8] - 361 Degrees (01361.HK) reported strong Q3 performance with a 10% increase in adult and children's apparel sales in offline channels and a 20% increase in e-commerce sales, projecting net profits of 1.261 billion yuan for 2025 [14] - Xingyu (601799.SH) established a robotics subsidiary to expand into the emerging robotics sector, while maintaining strong growth in its core automotive lighting business, with a projected net profit of 1.7 billion yuan for 2025 [16][17] Group 3: Industry Trends - The basic chemical sector is experiencing a configuration opportunity, with a significant adjustment in the index from a peak of 9565.18 points to a low of 3876.11 points, a cumulative decline of 59.5% [12] - Strategic metals are expected to see a revaluation due to geopolitical tensions, with a focus on rare earths, tungsten, and antimony as potential investment opportunities [9][11] - The liquid cooling market is anticipated to grow, with East Sunshine's acquisition of Qinhuai Data expected to enhance its capabilities in AI infrastructure and cooling solutions [13]

关于向 2025 年限制性股票激励计划激励对象 授予限制性股票的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 广州多浦乐电子科技股份有限公司（以下简称"公司"）2025 年限制 性股票激励计划（以下简称"本激励计划"）规定的限制性股票授予条件已 成就，根据公司 2025 年第二次临时股东大会的授权，公司于 2025 年 10 月 10 日召开第二届董事会第二十二次会议、第二届监事会第二十二次会议， 审议通过了《关于向 2025 年限制性股票激励计划激励对象授予限制性股票 的议案》，同意确定本激励计划限制性股票授予日为 2025 年 10 月 10 日， 并向符合授予条件的 72 名激励对象共计授予 92.00 万股限制性股票，授予 价格为 30.55 元/股，现将有关事项说明如下： 一、本激励计划简述 2025 年 9 月 29 日，公司召开 2025 年第二次临时股东大会，审议通过 股权激励方式：第二类限制性股票 限制性股票授予日：2025 年 10 月 10 日 限制性股票授予数量：92.00 万股 限制性股票授予价格：30.55 ...